A multicenter, randomized, double-blind, double-dummy, placebo-controlled, 3-way crossover, single dose study, comparing the efficacy and safety of the Fluticasone/Salmeterol combination administered with Elpenhaler db (Rolenium) versus the innovative one (Seretide Diskus) in patients with asthma.
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 07 Jul 2011 This study has been completed in Hungary and discontinued in Greece.
- 07 Jul 2011 New trial record